Collette Beckett, 27, had set up her own clothing brand and was living her best life when she was struck down by an extreme stabbing sensation in her hip bone ...

YESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced that YESINTEK™ (ustekinumab-kfce) is now ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the randomised Phase IIb RELIEVE UCCD trial of human ...

After a smash 2024 premiere in Melbourne, Hollywood and London, Popera: Sex, Death & Politics will make its Adelaide Fringe ...

Visitors look at a poster of South Korean pharmaceutical giant Celltrion Inc. during the 2025 European Crohn's and Colitis ...

A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...

Steven Frayne, formerly known as the illusionist and magician Dynamo, said he hoped Bradford's City of Culture year would "change lives and create its own type of magic".

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then, he's found a way to manage the disease with treatment and a strict diet.